Literature DB >> 9239705

Hormonal regulation of expression of messenger RNA encoding insulin-like growth factor binding proteins in human endometrial stromal cells cultured in vitro.

H C Liu1, Z Y He, C Mele, M Damario, O Davis, Z Rosenwaks.   

Abstract

To investigate the presence of messenger RNA (mRNA) encoding insulin-like growth factor binding proteins (IGFBP) in human secretory endometrial stromal cells cultured in vitro, total cellular mRNA and protein extracted from cells treated with various hormones were detected and identified by Northern and Western blotting techniques respectively. Northern blot analysis detected 1.4 and 2.5 kilobase (kb) mRNA transcripts for IGFBP-2 and IGFBP-3 respectively, in both control and progestin-treated human endometrial stromal cells in vitro. However, the 1.5 kb mRNA transcript of IGFBP-1 was detected only in progestin-treated cells but not in the controls. Progestin alone markedly stimulated cellular BP-1 protein and mRNA, but only moderately stimulated cellular IGFBP-2 and IGFBP-3 protein mRNA in a dose-dependent fashion. Adding relaxin at the same time as progestin further enhanced the stimulatory effects of progesterone. Oestradiol had a stimulatory effect on cellular IGFBP-2 mRNA, but had an inhibitory effect on protein and mRNA of IGFBP-3, also in a dose-dependent fashion. In general, for each specific binding protein, the amount of cellular mRNA correlated well with the amount of cellular protein. Therefore, IGFBP protein and mRNA transcript in human secretory endometrial stromal cells appears to be under hormonal influence. These hormones may control the synthesis of IGFBPs at the transcription rather than the translation level.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9239705     DOI: 10.1093/molehr/3.1.21

Source DB:  PubMed          Journal:  Mol Hum Reprod        ISSN: 1360-9947            Impact factor:   4.025


  5 in total

1.  Expression of inhibin/activin subunits and their receptors and binding proteins in human preimplantation embryos.

Authors:  Z Y He; H C Liu; C A Mele; L Barmat; L L Veeck; O Davis; Z Rosenwaks
Journal:  J Assist Reprod Genet       Date:  1999-02       Impact factor: 3.412

2.  Immunohistochemical analysis of insulin-like growth factor-binding proteins -1, -2, and -3 in implantation sites of the mouse.

Authors:  M A Damario; H C Liu; C A Mele; M G Horenstein; Z Rosenwaks
Journal:  J Assist Reprod Genet       Date:  1998-09       Impact factor: 3.412

3.  A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancer.

Authors:  Marc J Gunter; Donald R Hoover; Herbert Yu; Sylvia Wassertheil-Smoller; Joann E Manson; Jixin Li; Tiffany G Harris; Thomas E Rohan; Xiaonan Xue; Gloria Y F Ho; Mark H Einstein; Robert C Kaplan; Robert D Burk; Judith Wylie-Rosett; Michael N Pollak; Garnet Anderson; Barbara V Howard; Howard D Strickler
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-04       Impact factor: 4.254

4.  Estrogen and progesterone-related gene variants and colorectal cancer risk in women.

Authors:  Jennifer H Lin; JoAnn E Manson; Peter Kraft; Barbara B Cochrane; Marc J Gunter; Rowan T Chlebowski; Shumin M Zhang
Journal:  BMC Med Genet       Date:  2011-05-31       Impact factor: 2.103

5.  Significant role of estrogen and progesterone receptor sequence variants in gallbladder cancer predisposition: a multi-analytical strategy.

Authors:  Anshika Srivastava; Kiran Lata Sharma; Neena Srivastava; Sanjeev Misra; Balraj Mittal
Journal:  PLoS One       Date:  2012-07-10       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.